Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Rexahn Pharmaceuticals Company Profile (NYSE:RNN)

Consensus Ratings for Rexahn Pharmaceuticals (NYSE:RNN) (?)
Ratings Breakdown: 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $2.25 (188.46% upside)

Analysts' Ratings History for Rexahn Pharmaceuticals (NYSE:RNN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
1/15/2015ZacksDowngradeOutperform -> Neutral$1.00ViewTweet This Rating  Share This Rating on StockTwits
12/16/2014ZacksUpgradeNeutral -> Outperform$0.80ViewTweet This Rating  Share This Rating on StockTwits
9/16/2014LaidlawInitiated CoverageBuy$3.50ViewTweet This Rating  Share This Rating on StockTwits
3/24/2014Brinson PatrickInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
1/9/2014Roth CapitalInitiated CoverageBuy$3.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/5/2013 forward)